Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Polycystic Ovary Syndrome 1Non-alcoholic Fatty Liver Disease 1Lung Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 6Carboplatin 6Radiotherapy 5olaparib 4Surveys and Questionnaires 4Cisplatin 4Surgical Procedures, Operative 3Sentinel Lymph Node Biopsy 3Metformin 3pembrolizumab 2lenvatinib 2durvalumab 2dostarlimab 2anlotinib 2Reverse Transcriptase Polymerase Chain Reaction 2Progesterone 2Magnetic Resonance Spectroscopy 2Injections 2High-Energy Shock Waves 2Hematologic Tests 2Genetic Testing 2Docetaxel 2Blood Specimen Collection 2Base Sequence 2Amplified Fragment Length Polymorphism Analysis 2vistusertib 1serabelisib 1pazopanib 1palbociclib 1onapristone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Endometrial Neoplasms × Canagliflozin × Clear all
NCT04073680 2020-05-21

A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

Petra Pharma

Phase 1/2 Unknown
60 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡